Bennett Associates Wealth Management Acquires 233 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Bennett Associates Wealth Management raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 55.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 652 shares of the healthcare conglomerate’s stock after purchasing an additional 233 shares during the period. Bennett Associates Wealth Management’s holdings in UnitedHealth Group were worth $330,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Ullmann Wealth Partners Group LLC increased its position in UnitedHealth Group by 6.9% during the fourth quarter. Ullmann Wealth Partners Group LLC now owns 1,415 shares of the healthcare conglomerate’s stock worth $716,000 after acquiring an additional 91 shares during the period. Fermata Advisors LLC increased its holdings in shares of UnitedHealth Group by 124.8% during the fourth quarter. Fermata Advisors LLC now owns 1,360 shares of the healthcare conglomerate’s stock worth $688,000 after purchasing an additional 755 shares during the period. Cypress Wealth Services LLC grew its position in UnitedHealth Group by 5.5% during the fourth quarter. Cypress Wealth Services LLC now owns 1,525 shares of the healthcare conglomerate’s stock worth $771,000 after buying an additional 80 shares in the last quarter. Congress Park Capital LLC raised its holdings in UnitedHealth Group by 3.3% in the 4th quarter. Congress Park Capital LLC now owns 1,085 shares of the healthcare conglomerate’s stock valued at $549,000 after acquiring an additional 35 shares in the last quarter. Finally, Capital Advisors Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 22.5% during the 4th quarter. Capital Advisors Wealth Management LLC now owns 594 shares of the healthcare conglomerate’s stock worth $301,000 after purchasing an additional 109 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on UNH shares. UBS Group decreased their price objective on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a report on Friday, January 10th. Piper Sandler cut their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. Stephens increased their price target on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. Finally, StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and three have given a strong buy rating to the stock. According to MarketBeat, the company currently has an average rating of “Buy” and a consensus price target of $626.79.

UnitedHealth Group Stock Down 6.0 %

Shares of NYSE:UNH opened at $511.02 on Friday. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $470.28 billion, a price-to-earnings ratio of 33.29, a PEG ratio of 1.42 and a beta of 0.62. The business’s 50 day moving average is $553.38 and its 200 day moving average is $562.98. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same quarter in the previous year, the firm posted $5.83 earnings per share. The company’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were given a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.64%. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.